Back
Biogen, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
50
BIIB
Biogen, Inc.
Last Price:
$174.67
Seasonality Move:
8.72%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBiogen, Inc. Stock Forecast
-
Over the next 52 weeks, Biogen, Inc. has on average historically risen by 35.7% based on the past 34 years of stock performance.
-
Biogen, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
-
Is Biogen, Inc. Stock Undervalued?The current Biogen, Inc. [BIIB] share price is $174.80. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Biogen, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Biogen, Inc. has on average historically risen by 35.7% based on the past 34 years of stock performance.
Biogen, Inc. Stock Rating
Sell
50
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. overpriced?
-
Biogen, Inc. has risen higher in 20 of those 34 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.82%
Biogen, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
185.17
52-Week Low:
110.04
Prediction Charts
Market Cap:
25.6B
Price in USD:
174.80
Volume:
15M
Beta:
0.86
Technical Analysis
SMA50:
162.95
SMA100:
151.39
SMA200:
140.07
52-Wk Change:
18.6%
Stock Predictions
-
Is Biogen, Inc. stock public?Yes, Biogen, Inc. is a publicly traded company.
-
What is the Biogen, Inc. stock quote today?The Biogen, Inc. stock price is 174.80 USD today.
-
How to buy Biogen, Inc. stock online?You can buy Biogen, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 177.32 | 180.18 | 180.55 | 174.53 |
| Dec-3 | 180.17 | 180.75 | 182.94 | 178.05 |
| Dec-4 | 181.86 | 181.98 | 182.69 | 179.27 |
| Dec-5 | 181.96 | 181.30 | 183.15 | 181.10 |
| Dec-8 | 181.30 | 180.44 | 182.12 | 179.21 |
| Dec-9 | 179.91 | 175.84 | 181.99 | 175.39 |
| Dec-10 | 173.30 | 177.55 | 178.17 | 169.24 |
| Dec-11 | 177.47 | 172.50 | 180.79 | 172.00 |
| Dec-12 | 173.49 | 174.10 | 175.08 | 171.27 |
| Dec-15 | 173.67 | 175.74 | 175.94 | 170.45 |
| Dec-16 | 174.51 | 171.50 | 174.51 | 169.52 |
| Dec-17 | 171.43 | 172.10 | 173.83 | 169.55 |
| Dec-18 | 171.59 | 169.91 | 173.00 | 168.56 |
| Dec-19 | 171.32 | 174.80 | 176.42 | 170.00 |
Biogen, Inc. Earnings
Biogen, Inc. Earnings Report: Per Share Biogen, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen, Inc. Forecast Revenue Growth
Biogen, Inc. Stock Analysis: Historical quarterly revenues per share for Biogen, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.30 per share, and an increase next year of $0.15 per share.
* Biogen, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.